These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study. Lange BJ, Blatt J, Sather HN, Meadows AT. Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385 [Abstract] [Full Text] [Related]
6. [Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol]. Gu LJ, Li J, Xue HL, Tang JY, Chen J, Zhao HJ, Chen J, Ye H, Wang YP, Pan C. Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):1-4. PubMed ID: 14990066 [Abstract] [Full Text] [Related]
7. [Results and experiences with a modified BFM protocol for treatment of recurrences in children with acute lymphoblastic leukemia in East German areas]. Sauerbrey A, Zintl F, Malke H, Reimann M, Maaser M, Domula M, Dörffel W, Eggers G, Exadaktylos P, Kotte W. Klin Padiatr; 1993 Jan; 205(4):281-7. PubMed ID: 8377448 [Abstract] [Full Text] [Related]
11. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia]. Dłuzniewska A, Balwierz W, Balcerska A, Chybicka A, Kamieńska E, Karolczyk G, Karpińska-Derda I, Krawczuk-Rybak M, Kowalczyk JR, Lewandowska D, Maciejka-Kapuścińska L, Kołtano S, Malinowska I, Matysiak M, Mikołajczyk M, Mizia-Malarz A, Muszyńska-Rosłan K, Niedźwiedzki M, Pohorecka J, Sikorska-Fic B, Sobol G, Sońta-Jakimczyk D, Tomaszewska R, Urasiński T, Wachowiak J, Wieczorek M, Wójcik B, Wysocki M. Przegl Lek; 2010 Aug 20; 67(6):366-70. PubMed ID: 21344763 [Abstract] [Full Text] [Related]
12. Treatment outcome of adolescents with acute lymphoblastic leukemia. Irken G, Oren H, Gülen H, Duman M, Uçar C, Atabay B, Yilmaz S, Uysal K, Cevik N. Ann Hematol; 2002 Nov 20; 81(11):641-5. PubMed ID: 12454702 [Abstract] [Full Text] [Related]
13. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ. J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150 [Abstract] [Full Text] [Related]
18. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center]. de Diego-Floreschapa J, López-Hernández M, Borbolla-Escoboza JR, Trueba-Christy E, Carrillo-Rosales T, González-Avante M. Gac Med Mex; 1999 Apr 10; 135(3):253-8. PubMed ID: 10425822 [Abstract] [Full Text] [Related]
19. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Pediatr Blood Cancer; 2008 Nov 10; 51(5):621-5. PubMed ID: 18688848 [Abstract] [Full Text] [Related]